In this podcast we speak to experts from Lonza and Oxford Nanopore about their collaboration to bring direct mRNA sequencing (including N1-Methyl-pseudouridine) to a regulated environment and establish the new gold standard in sequencing technology.
We discuss how nanopore sequencing will be used to perform unbiased identity testing while enabling the simultaneous analyses of multiple critical quality attributes such as integrity (mRNA length and poly-A tail length) and capping.
Fler avsnitt av The Drug Discovery World Podcast
Visa alla avsnitt av The Drug Discovery World PodcastThe Drug Discovery World Podcast med Drug Discovery World (DDW) finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
